Skip to main content
Log in

Evaluation of risk factors for hearing impairment in at risk neonates by brainstem evoked response audiometry (BERA)

  • Original Articles
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Thirteen (19.2%) of 68 at risk neonates in an intensive care nursery with one or more adverse perinatal clinical factors viz; prematurity (<37 wks), low birth weight (<2000 gm), hyperbilirubinemia requiring active intervention, birth anoxia, neonatal seizures, infections, aminoglycoside administration, and craniofacial malformations; were diagnosed to have hearing impairment (elevated auditory threshold) by BERA testing performed within the first six weeks of life at a mean conceptional (gestational age + age after birth) age of 40.2±0.6 wks. As against this, 20 healthy term neonates who were examined at a mean conceptional age of 40.4±0.8 weeks had a normal hearing threshold of 30 db nHL. Elevated auditory threshold was found more frequently in neonates with multiple clinical adverse factors than in those having single risk factor (6/13 Vs 7/55, p<0.001). On multiple logistic regression analysis, however, only 2 factors viz; hyperbilirubinemia at level exceeding indication for exchange transfusion and birth weight <1500 gm, were found to be significantly correlated with the hearing impairment in the affected neonates and in that order of importance. Prematurity, birth asphyxia, neonatal seizures, infections and aminoglycoside administration had no significant correlation with hearing impairment. Since most of the neonates admitted to the neonatal ICU have one or more identified adverse risk factors, their hearing screening by BERA at the time of discharge seems justified.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Feinmesser M, Tell L, Levi H. Followup of 40,000 infants screened for hearing defect.Audiology 1982; 21: 197–203.

    Article  PubMed  CAS  Google Scholar 

  2. American Academy of Pediatrics, Joint Committee on Infant Hearing, Position statement.Pediatrics 1982; 70: 496.

    Google Scholar 

  3. Konigsmark BW.Genetic and Metabolic Deafness. Philadelphia; W.B. Saunders, 1976: p 419.

    Google Scholar 

  4. Hardy JB. Fetal consequences of maternal viral infections in pregnancy.Arch Otolaryngol 1973; 98: 218–227.

    PubMed  CAS  Google Scholar 

  5. Crosse VM, Meyer TC, Jerrard JW. Kenicterus & prematurity.Arch Dis Child 1955; 30: 501–508.

    PubMed  CAS  Google Scholar 

  6. Fisch L, Osborn DA. Congenital deafness & haemolytic disease of the newborn.Arch Dis Child 1954; 29: 309–316.

    Article  PubMed  CAS  Google Scholar 

  7. Flottorp G, Morley DE, Skatvedt M. The localization of hearing impairment in athetoids.Acta Otolaryngol 1957; 48: 404–414.

    Article  PubMed  CAS  Google Scholar 

  8. Schulman-Galambos C, Galambos R. Brainstem evoked response audiometry in newborn hearing screening.Arch Otolaryngol 1979; 105: 86–90.

    PubMed  CAS  Google Scholar 

  9. Picton TW, Durieux-Smith A. Auditory evoked potentials in the assessment of hearing.Neurol Clin 1988; 6(4): 791–808.

    PubMed  CAS  Google Scholar 

  10. Epstein CM. The use of brainstem auditory evoked potentials in the evaluation of the central nervous system.Neurol Clin 1988; 6(4): 771–789.

    PubMed  CAS  Google Scholar 

  11. Despland P, Galambos R. The auditory brainstem response (ABR) is a useful diagnostic tool in intensive care nursery.Pediatr Res 1980; 14: 154–158.

    Article  PubMed  CAS  Google Scholar 

  12. Picton TW, Taylor MJ, Durieux-Smith A, Edwards CG. Brainstem auditory evoked potentials in pediatrics. In: Aminoff MJ, ed.Electro Diagnosis in Clinical Neurology, 2nd edn, New York: Churchill-Livingstone, 1986: pp 505–534.

    Google Scholar 

  13. Kramer SJ, Vertes DR, Condon M. Auditory brainstem responses and clinical followup of high risk infants.Pediatrics 1989; 83(3): 385–392.

    PubMed  CAS  Google Scholar 

  14. Dubowitz LMS, Dubowitz V, Goldberg C. Clinical assessment of gestational age in the newborn infant.J Pediatr 1970; 77: 1–10.

    Article  PubMed  CAS  Google Scholar 

  15. Shannon DA, Felix JK, Krumholz A et al. Hearing screening of high risk newborn with brainstem auditory evoked potentials. A followup study.Pediatrics 1984; 73(1): 22–26.

    PubMed  CAS  Google Scholar 

  16. Alberti PW, Hyde ML, Riko K. An evaluation of BERA for hearing screening in high risk neonates.Laryngoscope 1983; 93: 1115–1121.

    Article  PubMed  CAS  Google Scholar 

  17. Mjoen S, Langslet A, Tangsrud SE, Sundby A. Auditory brainstem response (ABR) in high risk neonates.Acta Pediatr Scand 1982; 71: 711–715.

    Article  CAS  Google Scholar 

  18. Galambos R, Hicks G, Wilson MJ. Hearing loss in graduates of a tertiary intensive care nursery.Ear Hear 1982; 3: 87–90.

    Article  PubMed  CAS  Google Scholar 

  19. Bernard PA, Pechere JC. Hebert R. Altered objective audiometry in aminoglycosides treated human neonates.Arch Otorhino laryngol 1980; 228: 205–210.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gupta, A.K., Anand, N.K. & Raj, H. Evaluation of risk factors for hearing impairment in at risk neonates by brainstem evoked response audiometry (BERA). Indian J Pediatr 58, 849–855 (1991). https://doi.org/10.1007/BF02825449

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02825449

Key words

Navigation